Trials / Unknown
UnknownNCT02416609
Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer
Low-dose Radiotherapy as a Chemo-potentiator of a Induction Chemotherapy Regimen With Gem-based Doublets and Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- Azienda Ospedaliero-Universitaria di Modena · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this study is to evaluate if low-dose radiotherapy (LDR) can intensify local effect of a chemotherapy regimen with Gem-based doublets administered sequentially with stereotactic body radiotherapy (SBRT) and to assess the safety and efficacy of this combined treatment on patients affected by locally advanced pancreatic adenocarcinoma (LAPC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | LDR | LDR will be delivered during each cycle of Gem-based doublets |
| DRUG | Gem-based doublets | 4 cycles of Gem-based doublets |
| RADIATION | SBRT | SBRT will be administered after the fourth Gem-based doblet cycle, if no progression; three fractions will be administered |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2023-11-01
- Completion
- 2024-11-01
- First posted
- 2015-04-15
- Last updated
- 2022-12-12
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02416609. Inclusion in this directory is not an endorsement.